DICHIARA, MARIA
 Distribuzione geografica
Continente #
NA - Nord America 2.618
EU - Europa 2.166
AS - Asia 1.342
AF - Africa 251
SA - Sud America 195
Continente sconosciuto - Info sul continente non disponibili 194
OC - Oceania 8
Totale 6.774
Nazione #
US - Stati Uniti d'America 2.533
IT - Italia 849
SG - Singapore 658
RU - Federazione Russa 561
CN - Cina 347
DE - Germania 222
BR - Brasile 167
CI - Costa d'Avorio 155
IE - Irlanda 134
FI - Finlandia 109
VN - Vietnam 108
FR - Francia 69
KR - Corea 62
GB - Regno Unito 53
CA - Canada 52
BD - Bangladesh 37
ES - Italia 37
SN - Senegal 33
SE - Svezia 32
IN - India 24
JP - Giappone 24
NG - Nigeria 24
UA - Ucraina 24
HK - Hong Kong 20
ID - Indonesia 13
NL - Olanda 13
PL - Polonia 13
IQ - Iraq 12
ZA - Sudafrica 11
CZ - Repubblica Ceca 10
AR - Argentina 9
CL - Cile 9
BE - Belgio 8
KE - Kenya 7
MX - Messico 7
TR - Turchia 7
BJ - Benin 6
GR - Grecia 6
JM - Giamaica 6
AU - Australia 5
CR - Costa Rica 5
MA - Marocco 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
AT - Austria 4
EC - Ecuador 4
HU - Ungheria 4
CH - Svizzera 3
EG - Egitto 3
ET - Etiopia 3
IL - Israele 3
JO - Giordania 3
LT - Lituania 3
NZ - Nuova Zelanda 3
CO - Colombia 2
DO - Repubblica Dominicana 2
HN - Honduras 2
IR - Iran 2
KZ - Kazakistan 2
LB - Libano 2
NI - Nicaragua 2
NP - Nepal 2
PA - Panama 2
PY - Paraguay 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BZ - Belize 1
DK - Danimarca 1
GA - Gabon 1
GD - Grenada 1
GT - Guatemala 1
HR - Croazia 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
ME - Montenegro 1
MM - Myanmar 1
PE - Perù 1
PH - Filippine 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RO - Romania 1
TG - Togo 1
TN - Tunisia 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.581
Città #
Singapore 421
Dallas 380
Chandler 295
Santa Clara 293
Moscow 281
San Jose 208
Munich 187
Catania 174
Ashburn 159
Abidjan 155
Chicago 146
Dublin 133
Hefei 81
Helsinki 81
Beijing 66
Naples 63
Seoul 61
Civitanova Marche 60
Los Angeles 57
Boardman 54
Council Bluffs 54
Lauterbourg 42
New York 37
Ho Chi Minh City 35
Cambridge 34
Lawrence 34
Rome 34
Dakar 33
Andover 31
Milan 29
Nanjing 28
Hanoi 26
Bremen 21
Buffalo 21
Des Moines 21
Hong Kong 20
Houston 20
Tokyo 20
Toronto 20
Palermo 19
Phoenix 19
São Paulo 18
Denver 17
Jacksonville 17
Montreal 17
Cuneo 15
Brooklyn 14
Madrid 14
The Dalles 14
Lagos 13
Orem 13
Columbus 12
Jyväskylä 12
Messina 12
Bari 11
London 11
Poplar 11
Centro 10
Warsaw 10
Florence 9
Jakarta 9
Johannesburg 9
Abuja 8
Brno 8
Lappeenranta 8
Sala Baganza 8
San Francisco 8
Atlanta 7
Cagliari 7
Hebei 7
Mascalucia 7
Pozzallo 7
Santiago 7
Shenyang 7
Stockholm 7
Wilmington 7
Belo Horizonte 6
Brussels 6
Changsha 6
Cotonou 6
Da Nang 6
Marseille 6
Nanchang 6
Saint Petersburg 6
Scafati 6
Seattle 6
Terrassa 6
Amsterdam 5
Basingstoke 5
Bologna 5
Boston 5
Chennai 5
Civitavecchia 5
Dong Ket 5
Groningen 5
Guangzhou 5
Paris 5
Raffadali 5
Aci Catena 4
City of London 4
Totale 4.453
Nome #
Comprehensive data on a 2D-QSAR model for Heme Oxygenase isoform 1 inhibitors 302
Composti inorganici [Cap. 6] 281
Design, synthesis, and pharmacological evaluation of NO donor-sigma receptors hybrids for the treatment of cancer 204
Combination of heme oxygenase-1 inhibition and sigma receptor modulation for anticancer activity 195
Design and Synthesis of Tetrahydropyrrolo[3,4‐c]Pyrazole Sigma‐1 Receptor Ligands 190
(+)-Methyl (1R,2S)-2-{[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]methyl}-1-phenylcyclopropanecarboxylate [(+)-MR200] Derivatives as Potent and Selective Sigma Receptor Ligands: Stereochemistry and Pharmacological Properties 183
Development of a Sigma-2 Receptor affinity filter through a Monte Carlo based QSAR analysis 183
Heme Oxygenase Database (HemeOxDB) and QSAR Analysis of Isoform 1 Inhibitors 167
Design, Synthesis, and Cytotoxic Assessment of New Haloperidol Analogues as Potential Anticancer Compounds Targeting Sigma Receptors 165
Haloperidol Metabolite II Valproate Ester (S)-(-)-MRJF22: Preliminary Studies as a Potential Multifunctional Agent Against Uveal Melanoma 164
Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. A comprehensive systematic review 163
Exploiting the Power of Stereochemistry in Drug Action: 3-[(2S,6S,11S)-8-Hydroxy-6,11-dimethyl-1,4,5,6-tetrahydro-2,6-methano-3-benzazocin-3(2H)-yl]-N-phenylpropanamide as Potent Sigma-1 Receptor Antagonist 160
Development of Sigma Receptors Nitric Oxide Photodonor Ligands with Antiproliferative Activity 158
Design, synthesis and biological evaluation of novel aminopropylcarboxamide derivatives as sigma ligands 151
Novel N-Substituted Benzomorphan-Based Compounds: From MOR-Agonist/DOR-Antagonist to Biased/Unbiased MOR Agonists 146
Dual Sigma-1 receptor antagonists and hydrogen sulfide-releasing compounds for pain treatment: Design, synthesis, and pharmacological evaluation 145
Cytotoxicity Profiles and Neuroprotective Properties of the Novel Ifenprodil Analogues as Sigma Ligands 142
Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents 142
New selective Sigma-1/HDACi prodrugs for neurodegenerative disorders 136
La modellistica molecolare applicata ai recettori Sigma-1 e Sigma-2: un excursus 136
CNS permeability parameters determination through a statistical analysis driven approach 136
Development of NO-releasing sigma receptor hybrids as anticancer agents 135
Correction to Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents 134
Discovery of first novel sigma/HDACi dual-ligands with a potent in vitro antiproliferative activity 133
Tumor Targeting Sigma Receptor Ligands: Development of New Molecular Hybrids as Anticancer Therapeutics 133
Development of novel H2S-donor sigma receptor hybrids for the management of pain. 132
Novel Sigma-1 receptor antagonists: From opioids to small molecules: What is new? 132
Sigma-2 receptor ligands QSAR model dataset 130
Targeting heme Oxygenase-1 with hybrid compounds to overcome Imatinib resistance in chronic myeloid leukemia cell lines 128
Novel N-normetazocine Derivatives with Opioid Agonist/Sigma-1 Receptor Antagonist Profile as Potential Analgesics in Inflammatory Pain 127
Novel Sigma Receptors Ligands-Nitric Oxide Photodonor: Molecular Hybrids for Double-Targeted Antiproliferative Effect 123
Morphing of ibogaine: A successful attempt into the search for sigma-2 receptor ligands 122
Exploring Structural Requirements for Sigma-1 Receptor Linear Ligands: Experimental and Computational Approaches 120
Discovery of AD258 as a Sigma Receptor Ligand with Potent Antiallodynic Activity 120
Targeting the hydrophobic heme oxygenase-1 western region for the identification of novel and selective azole-based inhibitors. 120
New Insights into the Opioid Analgesic Profile of cis-(-)-N-Normetazocine-derived Ligands 119
Hyphenated 3D-QSAR statistical model-scaffold hopping analysis for the identification of potentially potent and selective sigma-2 receptor ligands 115
Sigma Receptor Ligands Carrying a Nitric Oxide Donor Nitrate Moiety: Synthesis, In Silico, and Biological Evaluation 109
Synthesis, Computational Insights, and Evaluation of Novel Sigma Receptors Ligands 105
Identification of Potentially Potent Heme Oxygenase 1 Inhibitors through 3D-QSAR Coupled to Scaffold-Hopping Analysis 96
Discovery and computational studies of piperidine/piperazine-based compounds endowed with sigma receptor affinity 92
Recent advances in drug discovery of phototherapeutic non-porphyrinic anticancer agents 88
Development of selective sigma-1 receptor ligands with antiallodynic activity: A focus on piperidine and piperazine scaffolds 87
Synthesis and evaluation of haloperidol metabolite II prodrugs as anticancer agents 85
Sintesi e valutazione preclinica di ligandi per i recettori sigma utili per il trattamento dei tumori e per la gestione del dolore 84
Dual Piperidine-Based Histamine H3 and Sigma-1 Receptor Ligands in the Treatment of Nociceptive and Neuropathic Pain 81
Structural and Molecular Insight into Piperazine and Piperidine Derivatives as Histamine H3 and Sigma-1 Receptor Antagonists with Promising Antinociceptive Properties 81
Repurposing of human kinase inhibitors in neglected protozoan diseases 76
H2S releasing molecules in pharmaceutical development 71
DESIGN AND SYNTHESIS OF NOVEL, STRUCTURALLY SIMPLIFIED σ/HDAC DUAL-TARGET PRODRUGS 47
Totale 6.774
Categoria #
all - tutte 20.618
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.618


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022236 0 0 0 15 47 4 42 8 23 16 4 77
2022/2023745 69 66 15 107 49 116 8 123 143 9 34 6
2023/2024435 21 58 17 19 37 133 21 19 1 8 70 31
2024/20251.602 55 214 56 125 221 200 201 105 163 82 92 88
2025/20262.901 181 145 442 215 399 650 263 56 180 166 94 110
2026/2027313 80 136 84 13 0 0 0 0 0 0 0 0
Totale 6.774